Key result
Tailored renal replacement therapy achieves favorable outcomes in ~40% of hemodialysis patients developing post-revascularization CHS.
Why the study?
Revascularization for internal carotid artery stenosis in hemodialysis patients carries a high risk of perioperative complications, and strategies for managing cerebral hyperperfusion syndrome in this population remain poorly defined.
Case Report (n=5)
Tailored renal replacement therapies (such as continuous hemodiafiltration and sustained low-efficiency dialysis) combined with continuous near-infrared spectroscopy monitoring can help maintain hemodynamic stability and achieve favorable functional outcomes in hemodialysis patients who develop cerebral hyperperfusion syndrome after carotid revascularization.
Answers are grounded in this paper and cite their sources.
High cerebral hyperperfusion syndrome incidence after carotid revascularization in hemodialysis patients; leaves open benefit of tailored renal replacement therapy.
Background: Revascularization for internal carotid artery stenosis in hemodialysis (HD) patients is associated with a high risk of perioperative complications. In particular, strategies for managing cerebral hyperperfusion syndrome (CHS) in this population remain poorly defined. Here, we present two cases of HD patients with severe carotid stenosis who developed CHS following revascularization and presented significant multidisciplinary management challenges. Case Description: Between 2012 and 2025, five HD patients underwent carotid revascularization (three carotid endarterectomy [CEA] and two carotid artery stenting procedures). Among them, two patients developed postoperative CHS. Both patients were diabetic and exhibited severe high-risk features preoperatively, including near-occlusion with progressive stroke and impaired cerebrovascular reactivity. Despite stringent blood pressure control under postoperative general anesthesia, both patients presented with seizures, and impaired consciousness persisted for more than 2 weeks. Management was further complicated by marked hemodynamic instability; fluid removal during HD caused precipitous blood pressure drops, while concurrent infections required intensive care. Tailored renal replacement therapies (RRT) – including continuous hemodiafiltration, extracorporeal ultrafiltration, and sustained low-efficiency dialysis, which played a key role in maintaining hemodynamic stability – alongside continuous near-infrared spectroscopy monitoring as a useful adjunct, aided in navigating these complex scenarios, leading to favorable functional outcomes. Conclusion: Managing CHS in HD patients involves navigating interrelated systemic and neurological complexities, particularly regarding hemodynamic stability, sedation weaning, and infectious complications. Tailored RRT modalities and multi-modal monitoring provide practical strategies to manage these vulnerable patients, though larger studies are required to define optimal management protocols.
No takes yet. Share an insight, caveat, or question.
Haraguchi et al. (2026) conducted a case report in Internal carotid artery stenosis in hemodialysis patients (n=5). Carotid revascularization (carotid endarterectomy or carotid artery stenting) with tailored renal replacement therapy and near-infrared spectroscopy monitoring was evaluated on Postoperative cerebral hyperperfusion syndrome (CHS). Carotid revascularization in 5 hemodialysis patients resulted in postoperative cerebral hyperperfusion syndrome in 2, who achieved favorable outcomes with tailored renal replacement therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: